Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Queensland Health
Merck
Mallinckrodt
Cipla
Cantor Fitzgerald
McKesson
Johnson and Johnson
Boehringer Ingelheim

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AVANAFIL

« Back to Dashboard

Clinical Trials for Avanafil

Trial ID Title Status Sponsor Phase Summary
NCT00769041 A Thorough EKG Safety Study of TA-1790 (Avanafil) Completed Covance Phase 1 This study is to assess whether treatment with a therapeutic (100 mg) or supratherapeutic (800 mg) dose of avanafil has the potential to cause QT/QTc prolongation in healthy volunteers.
NCT00769041 A Thorough EKG Safety Study of TA-1790 (Avanafil) Completed VIVUS, Inc. Phase 1 This study is to assess whether treatment with a therapeutic (100 mg) or supratherapeutic (800 mg) dose of avanafil has the potential to cause QT/QTc prolongation in healthy volunteers.
NCT00770042 To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil Completed VIVUS, Inc. Phase 1 This study is being conducted to examine the effect of three CYP3A4 inhibitors (ketoconazole, erythromycin and ritonavir) on the single dose pharmacokinetics of avanafil. Ketoconazole and ritonavir are potent inhibitors of CYP3A4 and erythromycin is a moderate CYP3A4 inhibitor. Any interaction that is observed would be predictive of other inhibitors of CYP3A4.
NCT00790751 Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED Completed VIVUS, Inc. Phase 3 This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.
NCT00809471 Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) Completed VIVUS, Inc. Phase 3 This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.
NCT00853606 Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction Completed VIVUS, Inc. Phase 3 This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Avanafil

Condition Name

Condition Name for Avanafil
Intervention Trials
Erectile Dysfunction 18
Sexual Function and Fertility Disorders NEC-Erectile Dysfunction 1
Semen Exposure 1
Renal 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Avanafil
Intervention Trials
Erectile Dysfunction 19
Urinary Incontinence 1
Urinary Bladder, Overactive 1
Enuresis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Avanafil

Trials by Country

Trials by Country for Avanafil
Location Trials
United States 88
Korea, Republic of 3
Russian Federation 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Avanafil
Location Trials
Arizona 8
Florida 6
Ohio 5
North Carolina 5
New York 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Avanafil

Clinical Trial Phase

Clinical Trial Phase for Avanafil
Clinical Trial Phase Trials
Phase 4 3
Phase 3 7
Phase 2 1
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Avanafil
Clinical Trial Phase Trials
Completed 22
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Avanafil

Sponsor Name

Sponsor Name for Avanafil
Sponsor Trials
VIVUS, Inc. 18
JW Pharmaceutical 2
Astellas Pharma US, Inc. 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Avanafil
Sponsor Trials
Industry 23
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Cipla
Express Scripts
QuintilesIMS
Chinese Patent Office
Farmers Insurance
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.